main-logo

ICD-10 Code C90.01 | Multiple myeloma in remission Symptoms, Diagnosis, Billing

Multiple myeloma in remission is a hematological malignancy characterized by the proliferation of monoclonal plasma cells in the bone marrow. The condition is significant as it can lead to various complications, including bone lesions, renal impairment, and immune dysfunction. Accurate coding with ICD-10 Code C90.01 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that patients receive appropriate care and resources.

What is ICD-10 Code C90.01 for Multiple myeloma in remission?

ICD-10 Code C90.01 represents Multiple myeloma in remission, indicating a state where the disease is not actively causing symptoms or complications. This code is used when documenting patients who have undergone treatment and are currently free from disease activity, allowing for accurate clinical documentation and billing in healthcare settings.

ICD-10 Code C90.01 – Clinical Definition and Explanation of Multiple myeloma in remission

Multiple myeloma in remission occurs when the malignant plasma cells are no longer detectable, and the patient exhibits no symptoms related to the disease. This condition requires ongoing medical attention to monitor for potential relapse and manage any residual effects of prior treatments.

Key Clinical Features:

  • Absence of symptoms such as bone pain, fatigue, or anemia.
  • Normal laboratory findings, including serum protein electrophoresis.
  • Stable renal function and absence of hypercalcemia.
  • Regular follow-up to monitor for signs of relapse.

ICD-10 Code C90.01 for Multiple myeloma in remission – SOAP Notes & Clinical Use

ICD-10 Code C90.01 is utilized in SOAP notes to document the patient's remission status, guiding clinical assessments and treatment plans. It plays a crucial role in both acute and chronic care settings, ensuring that healthcare providers accurately capture the patient's health status and treatment progress.

What Does ICD-10 Code C90.01 for Multiple myeloma in remission Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C90.01 connects subjective reports of patient well-being with objective clinical findings, confirming the diagnosis of remission. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code C90.01 – Multiple myeloma in remission

While patients with Multiple myeloma in remission may not require active treatment, ongoing monitoring and supportive care are essential to maintain health and prevent complications.

Antibiotic Therapy:

  • Not typically indicated unless there is an infection; consider first-line antibiotics such as ceftriaxone for bacterial infections.
  • Alternative options may include clindamycin or vancomycin based on sensitivity.
  • Duration of therapy usually ranges from 7 to 14 days, depending on the infection.

Supportive Care:

  • Regular monitoring of blood counts and renal function.
  • Management of any residual symptoms such as fatigue or pain.
  • Nutritional support and counseling to maintain overall health.

Infection Control:

  • Encourage hand hygiene and vaccination against preventable infections.
  • Monitor for signs of infection, especially in patients with a history of immunosuppression.
  • Educate patients on avoiding exposure to sick individuals.

How to Document Symptoms of Multiple myeloma in remission (ICD-10 C90.01) in SOAP Notes

Subjective:

  • Patient reports feeling well with no new symptoms.
  • Denies bone pain, fatigue, or signs of infection.
  • History of previous treatment for multiple myeloma.

Objective:

  • Vital signs within normal limits.
  • Laboratory results show normal serum protein levels.
  • No signs of anemia or hypercalcemia on examination.
card-topcard-bottom

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more
hipaa-icon

SOAP Note Guidelines for Diagnosing Multiple myeloma in remission (ICD-10 Code C90.01)

Assessment:

  • Diagnosis: Multiple myeloma in remission, stable condition.
  • ICD-10 Code: C90.01.
  • No current symptoms or complications noted.

Plan:

  • Continue regular follow-up appointments every 3-6 months.
  • Monitor blood counts and renal function regularly.
  • Educate the patient on signs of potential relapse.

Treatment & Plan Section for ICD-10 Code C90.01 – Multiple myeloma in remission

  • Regular monitoring of health status and laboratory parameters.
  • Supportive care to manage any residual symptoms.
  • Patient education on lifestyle modifications and signs of relapse.
  • Scheduled follow-up visits to ensure ongoing remission.

Using ICD-10 Code C90.01 for Multiple myeloma in remission in Billing & SOAP Note Compliance

  • Ensure accurate documentation of patient status in Subjective (S) and Objective (O) sections.
  • Use C90.01 when the patient is confirmed to be in remission without active disease.
  • Align treatment plans with clinical guidelines to support justified billing.
  • Include relevant CPT codes that correspond to the services provided.

ICD-10 Code C90.01 in Medical Billing and Insurance for Multiple myeloma in remission

ICD-10 Code C90.01 is crucial in medical billing, particularly in hospital, ER, or infectious disease care settings.

Billing Notes:

  • Document the patient's remission status clearly to support claims.
  • Use C90.01 in conjunction with other relevant codes for comprehensive billing.
  • Ensure that all chart elements reflect the patient's current health status.

Common CPT Pairings:

CPT CodeDescription
99213Established patient office visit, low complexity.
36415Collection of venous blood by venipuncture.
85025Complete blood count with automated differential.

Frequently Asked Questions

Common Questions About Using ICD-10 Code C90.01 for Multiple myeloma in remission

What does it mean for multiple myeloma to be in remission?

Remission in multiple myeloma indicates that the disease is not currently active, with no detectable symptoms or signs of disease progression. Regular monitoring is essential to ensure that the patient remains in remission.

How often should patients with multiple myeloma in remission be monitored?

Patients in remission should typically have follow-up appointments every 3 to 6 months to monitor for any signs of relapse and to assess overall health.

Can patients with multiple myeloma in remission experience complications?

Yes, even in remission, patients may experience complications related to previous treatments or the disease itself, such as bone health issues or renal function changes.

Is treatment necessary for patients with multiple myeloma in remission?

Active treatment is generally not required for patients in remission, but supportive care and monitoring are crucial to maintain health and prevent complications.

diamond-bg
diamond-bg

Get started with your 20 free notes

Sign up for free
main-logo

AI-aided Sudsy Shorthand for ink-free practices

support@soapsuds.io
hipaa-logo

Clinical Notes

SOAP notes

DAP notes

AI medical notes

© Copyright SOAPsuds 2025. All rights reserved